Current risk estimate of breast implant–associated anaplastic large cell lymphoma in textured breast implants
DJ Collett, H Rakhorst, P Lennox… - Plastic and …, 2019 - journals.lww.com
Background: With breast implant–associated anaplastic large cell lymphoma (BIA-ALCL)
now accepted as a unique (iatrogenic) subtype of ALCL directly associated with textured …
now accepted as a unique (iatrogenic) subtype of ALCL directly associated with textured …
Key players in the immune response to biomaterial scaffolds for regenerative medicine
L Chung, DR Maestas Jr, F Housseau… - Advanced drug delivery …, 2017 - Elsevier
The compatibility of biomaterials is critical to their structural and biological function in
medical applications. The immune system is the first responder to tissue trauma and to a …
medical applications. The immune system is the first responder to tissue trauma and to a …
Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk
A Loch-Wilkinson, KJ Beath, RJW Knight… - Plastic and …, 2017 - journals.lww.com
Background: The association between breast implants and breast implant–associated
anaplastic large cell lymphoma (ALCL) has been confirmed. Implant-related risk has been …
anaplastic large cell lymphoma (ALCL) has been confirmed. Implant-related risk has been …
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann… - JAMA …, 2018 - jamanetwork.com
Importance Breast implants are among the most commonly used medical devices. Since
2008, the number of women with breast implants diagnosed with anaplastic large-cell …
2008, the number of women with breast implants diagnosed with anaplastic large-cell …
Capsular contracture after breast augmentation: an update for clinical practice
H Headon, A Kasem, K Mokbel - Archives of plastic surgery, 2015 - thieme-connect.com
Capsular contracture is the most common complication following implant based breast
surgery and is one of the most common reasons for reoperation. Therefore, it is important to …
surgery and is one of the most common reasons for reoperation. Therefore, it is important to …
Silicone implants and lymphoma: The role of inflammation
The risk of hematological malignancies is mainly determined by genetic background, age,
sex, race and ethnicity, geographic location, exposure to certain chemicals and radiation; …
sex, race and ethnicity, geographic location, exposure to certain chemicals and radiation; …
Bacterial adhesion and biofilm formation on textured breast implant shell materials
GA James, L Boegli, J Hancock, L Bowersock… - Aesthetic plastic …, 2019 - Springer
Background Bacterial biofilms have been implicated with breast implant complications
including capsular contracture and anaplastic large-cell lymphoma. The actual mechanisms …
including capsular contracture and anaplastic large-cell lymphoma. The actual mechanisms …
Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent
L Johnson, JM O'donoghue, N McLean, P Turton… - European Journal of …, 2017 - Elsevier
Background Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare,
Non-Hodgkin lymphoma arising in the capsule of breast implants. BIA-ALCL presents as a …
Non-Hodgkin lymphoma arising in the capsule of breast implants. BIA-ALCL presents as a …
Anaplastic large cell lymphoma in paediatric and young adult patients
Anaplastic large cell lymphoma (ALCL) is a heterogeneous disease of debateable origin
that, in children, is largely anaplastic lymphoma kinase (ALK) positive with aberrant ALK …
that, in children, is largely anaplastic lymphoma kinase (ALK) positive with aberrant ALK …
[HTML][HTML] The plasticity of biocompatibility
DF Williams - Biomaterials, 2023 - Elsevier
Biocompatibility concerns the phenomena that occur within the interactions between
biomaterials and human patients, which ultimately control the performance of many facets of …
biomaterials and human patients, which ultimately control the performance of many facets of …